AUGMENTIN XR Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Augmentin Xr, and when can generic versions of Augmentin Xr launch?

Augmentin Xr is a drug marketed by Us Antibiotics and is included in one NDA.

The generic ingredient in AUGMENTIN XR is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Augmentin Xr

A generic version of AUGMENTIN XR was approved as amoxicillin; clavulanate potassium by SANDOZ on March 14^th, 2002.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for AUGMENTIN XR?
What are the global sales for AUGMENTIN XR?
What is Average Wholesale Price for AUGMENTIN XR?

Summary for AUGMENTIN XR

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	15
Clinical Trials:	75
Patent Applications:	705
Drug Prices:	Drug price information for AUGMENTIN XR
DailyMed Link:	AUGMENTIN XR at DailyMed

Drug patent expirations by year for AUGMENTIN XR

Recent Clinical Trials for AUGMENTIN XR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Wisconsin, Madison	Phase 4
Patient-Centered Outcomes Research Institute	Phase 4
Daniel Merenstein	Phase 4

See all AUGMENTIN XR clinical trials

Paragraph IV (Patent) Challenges for AUGMENTIN XR

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
AUGMENTIN XR	Extended-release Tablets	amoxicillin; clavulanate potassium	1000 mg/62.5 mg	050785	1	2009-01-21

US Patents and Regulatory Information for AUGMENTIN XR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Us Antibiotics	AUGMENTIN XR	amoxicillin; clavulanate potassium	TABLET, EXTENDED RELEASE;ORAL	050785-001	Sep 25, 2002		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for AUGMENTIN XR

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Us Antibiotics	AUGMENTIN XR	amoxicillin; clavulanate potassium	TABLET, EXTENDED RELEASE;ORAL	050785-001	Sep 25, 2002	⤷ Sign Up	⤷ Sign Up
Us Antibiotics	AUGMENTIN XR	amoxicillin; clavulanate potassium	TABLET, EXTENDED RELEASE;ORAL	050785-001	Sep 25, 2002	⤷ Sign Up	⤷ Sign Up
Us Antibiotics	AUGMENTIN XR	amoxicillin; clavulanate potassium	TABLET, EXTENDED RELEASE;ORAL	050785-001	Sep 25, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for AUGMENTIN XR

See the table below for patents covering AUGMENTIN XR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Malaysia	119953	NOVEL METHOD OF TREATMENT	⤷ Sign Up
Brazil	0009719	PROCESSO DE TRATAMENTO	⤷ Sign Up
Canada	2366304	NOUVEAU PROCEDE DE TRAITEMENT (NOVEL METHOD OF TREATMENT)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for AUGMENTIN XR

Recent Clinical Trials for AUGMENTIN XR

Paragraph IV (Patent) Challenges for AUGMENTIN XR

Make Better Decisions: Try a trial or see plans & pricing